Mesoblast (MEOBF) Stock Chart & Stock Price History $1.54 0.00 (0.00%) As of 08/15/2025 Add Compare Share Share Chart Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestBuy This Stock Mesoblast Stock Price Performance The Mesoblast (MEOBF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 143.34%, with a year-to-date return of -30.00%. In the past month, the stock has increased 59.59%, reflecting recent market activity. As of the latest close, Mesoblast traded at $1.54 with a market cap of and volume of 0 shares. Five years ago, the stock traded at $3.68, representing a 58.15% decrease over that period. At the time, it had a market cap of and a volume of 4,500 shares. Receive MEOBF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Mesoblast and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month PerformanceN/A3 Month PerformanceN/AYear-To-Date Performance-30.00%1 Year PerformanceN/A5 Year Performance-58.15% MEOBF Stock Chart for Wednesday, August, 20, 2025 MEOBF Chart by TradingView Mesoblast Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$1.54$1.54$1.54$1.531,950 shs$0.0008/14/2025$1.51$1.54+1.99%$1.54$1.531,950 shs$0.0008/13/2025$1.51$1.51$1.51$1.51400 shs$0.0008/01/2025$1.51$1.51$1.51$1.51500 shs$0.0007/31/2025$1.51$1.51$1.51$1.51500 shs$0.0007/30/2025$0.97$1.51+56.48%$1.51$1.51500 shs$0.00 Related Companies 180 Life Sciences Stock Price Chart 4D pharma Stock Price Chart 4Front Ventures Stock Price Chart Abattis Bioceuticals Stock Price Chart Abcam Stock Price Chart Acusphere Stock Price Chart Aeolus Pharmaceuticals Stock Price Chart Aesther Healthcare Acquisition Stock Price Chart Agentix Stock Price Chart Ainos Stock Price Chart Receive MEOBF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Mesoblast and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:MEOBF) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored"I'm risking my reputation on this"A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...Crypto 101 Media | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesoblast Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesoblast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access